Navigating Insurance Coverage for Ketamine Therapy

Insurance coverage for ketamine therapy depends almost entirely on which form of treatment you're using. Spravato (esketamine), the FDA-approved nasal spray, is covered by most major commercial insurance plans, Medicare Part D, and a growing number of Medicaid programs, usually with prior authorization. Generic ketamine, given by IV, IM, sublingual tablet, or oral route for depression, anxiety, or PTSD, is prescribed off-label and is rarely covered by insurance for psychiatric use. That gap between the two categories is the single biggest factor in what you'll pay out of pocket.

This guide explains what each type of coverage typically includes, how prior authorization and appeals work, and practical ways to lower your costs whether or not your plan pays for treatment.

Two Coverage Categories: Spravato vs. Generic Ketamine

The single most important distinction in ketamine insurance coverage is between FDA-approved Spravato (esketamine) and off-label generic ketamine.

Spravato (Esketamine Nasal Spray)

The FDA approved Spravato in 2019 for treatment-resistant depression and expanded the approval in 2020 to major depressive disorder with acute suicidal ideation or behavior. Because it carries specific psychiatric indications, most major commercial insurance plans cover it, along with Medicare Part D. Medicaid coverage varies by state but continues to expand. See our comparison of ketamine and esketamine for how the two treatments differ clinically.

Coverage typically requires prior authorization and documentation that you meet diagnostic criteria: treatment-resistant depression, defined as failure of at least two adequate antidepressant trials, or major depressive disorder with suicidal ideation. Spravato must also be used alongside a newly initiated or ongoing oral antidepressant, and treatment must take place at a REMS-certified healthcare setting, a safety program the FDA requires for esketamine.

With insurance, typical out-of-pocket costs range from $0 to $200 per session depending on your plan's copay or coinsurance structure. The Janssen CarePath savings program can bring copays down to as low as $10 per session for commercially insured patients.

Generic Ketamine (IV, IM, Sublingual, Oral)

Generic ketamine used for depression, anxiety, PTSD, or other psychiatric conditions is prescribed off-label, meaning the FDA has not approved it for these uses even though the drug itself is approved as an anesthetic. Most insurance plans do not cover generic ketamine infusions or at-home sublingual programs for psychiatric indications. Compare oral and sublingual ketamine options if you're weighing at-home programs against clinic-based IV treatment.

The medication itself is inexpensive, often just a few dollars per dose, and may be covered at a compounding pharmacy with a prescription depending on your plan. The cost that adds up is administration, monitoring, and provider fees. Some components of treatment, including the initial psychiatric evaluation, vital sign monitoring, and follow-up visits, can sometimes be coded and submitted to insurance separately. A small but growing number of providers are also finding ways to bill portions of IV ketamine treatment under medical supervision codes.

Prior Authorization Timeline and Tips

Standard prior authorization requests typically take three to five business days, and urgent requests are usually decided within 24 to 72 hours. Many insurers have expedited pathways for patients with suicidal ideation.

A few things strengthen a request: thorough documentation of every medication tried, including doses and reasons for discontinuation; standardized assessment scores like the PHQ-9, which carry more weight than subjective descriptions alone; a clear letter of medical necessity from your provider explaining why standard treatments failed; and, where relevant, references to peer-reviewed research supporting ketamine or esketamine for your specific diagnosis.

What to Do If You're Denied

Insurance denials are common, but they are not final. According to Healthcare.gov, patients have the right to appeal a health plan's coverage decision, and appeals for Spravato in particular are often successful once the underlying documentation gap is addressed.

1. Read the denial letter carefully. Common reasons include insufficient documentation of treatment failures, not meeting diagnostic criteria, or the treatment being classified as experimental.
2. Ask your provider to request a peer-to-peer review, a direct conversation with the insurer's medical reviewer that can resolve issues paperwork alone cannot.
3. File a formal internal appeal with additional documentation addressing the specific denial reason, updated clinical notes, and a revised letter of medical necessity.
4. If the internal appeal is denied, file an external appeal. In most states, an independent reviewer not affiliated with your insurer will evaluate your case.
5. If you believe the denial is unjust, contact your state insurance commissioner, who can investigate and intervene.

Strategies to Reduce Out-of-Pocket Costs

For Spravato

The Janssen CarePath savings program can bring eligible commercially insured patients down to about $10 per session; ask your provider or check the program directly for enrollment details. Janssen also offers patient assistance programs for uninsured or underinsured patients that may cover the cost of the medication itself. If you have Medicare Part D and limited income, the Extra Help program can lower prescription drug costs.

For Generic Ketamine

Ask your clinic for a superbill, a detailed receipt with medical codes, even if they don't bill insurance directly. You can submit it for potential out-of-network reimbursement if your PPO plan offers those benefits and you've already met your out-of-network deductible. Ketamine therapy is generally considered a qualified expense for Health Savings Accounts and Flexible Spending Accounts, which lets you pay with pre-tax dollars. Many clinics also offer interest-free payment plans that spread the cost over several months.

Billing Codes That Matter

Knowing the codes your provider uses can help you verify coverage before treatment starts:

• 96365: intravenous infusion, initial (used for IV ketamine administration)
• 96366: intravenous infusion, each additional hour
• 99213-99215: evaluation and management codes for follow-up visits
• 90792: psychiatric diagnostic evaluation (initial consultation)
• S0013: esketamine nasal spray (Spravato-specific code)
• J3490: unclassified drug, sometimes used for compounded ketamine

Ask your provider which codes they use and verify with your insurance company whether those specific codes are covered under your plan.

Coverage Is Expanding, Slowly

Insurance coverage for ketamine therapy continues to change as clinical evidence accumulates. Some employers are adding ketamine therapy to mental health benefits, and a few insurers have started pilot programs for generic ketamine coverage. Advocacy organizations and professional societies continue to push for broader access. The current system is inconsistent, but the direction is toward more coverage, not less.

Helpful Resources

• SAMHSA National Helpline: a free, confidential 24/7 referral and information service for mental health and substance use disorders.
• Healthcare.gov: the federal health insurance marketplace for exploring coverage options.
• FindTreatment.gov: SAMHSA's treatment locator for mental health and substance use treatment facilities.
• Mayo Clinic: background on treatment-resistant depression and available therapies, including esketamine.

The financial side of ketamine therapy should not keep you from getting care. If you're ready to see what treatment involves before you call your insurer, our getting started guide walks through what to expect at each step.